iZafe Group AB (OSTO:IZAFE B) EV-to-EBIT : -5.79 (As of Jul. 08, 2025)

View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, iZafe Group AB's Enterprise Value is kr100.59 Mil. iZafe Group AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was kr-17.38 Mil. Therefore, iZafe Group AB's EV-to-EBIT for today is -5.79.

The historical rank and industry rank for iZafe Group AB's EV-to-EBIT or its related term are showing as below:

OSTO:IZAFE B' s EV-to-EBIT Range Over the Past 10 Years
Min: -39.31 Med: -3.59 Max: -0.72
Current: -5.79

During the past 13 years, the highest EV-to-EBIT of iZafe Group AB was -0.72. The lowest was -39.31. And the median was -3.59.

OSTO:IZAFE B's EV-to-EBIT is ranked worse than
100% of 459 companies
in the Medical Devices & Instruments industry
Industry Median: 20.03 vs OSTO:IZAFE B: -5.79

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. iZafe Group AB's Enterprise Value for the quarter that ended in Mar. 2025 was kr81.01 Mil. iZafe Group AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was kr-17.38 Mil. iZafe Group AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was -21.45%.

iZafe Group AB EV-to-EBIT Historical Data

The historical data trend for iZafe Group AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iZafe Group AB EV-to-EBIT Chart

iZafe Group AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-EBIT

Get a 7-Day Free Trial

-7.91

-1.31

-2.01

-1.94

-3.27

iZafe Group AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															-1.59	-1.92	-1.81	-3.27	-4.66

Competitive Comparison of iZafe Group AB's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, iZafe Group AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iZafe Group AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where iZafe Group AB's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

iZafe Group AB EV-to-EBIT Calculation

iZafe Group AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	100.592	/	-17.375
	=	-5.79

iZafe Group AB's current Enterprise Value is kr100.59 Mil.
iZafe Group AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-17.38 Mil.

iZafe Group AB (OSTO:IZAFE B) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

iZafe Group AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 )	=	EBIT	/	Enterprise Value (Q: Mar. 2025 )
	=	-17.375	/	81.008384
	=	-21.45 %

iZafe Group AB's Enterprise Value for the quarter that ended in Mar. 2025 was kr81.01 Mil.
iZafe Group AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-17.38 Mil.

iZafe Group AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

iZafe Group AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

M02:Germany

Address

David Bagares Gata 3, Stockholm, SWE, 111 38

Website

https://www.izafe.se

iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB Headlines

No Headlines